Replies to post #1859 on Medical Cannabis Payment Solutions (REFG)

[I-Man]

REFG in CNBC article::

The Cannabis Market is Projected to Rise Due to Medical Advancements
9:00 am ET May 30, 2018

According to a research by Oristep Consulting, the global medical cannabis market in 2016 was USD 12.67 billion and will reach USD 33.41 billion by 2022 at a CAGR of 17.53% during the forecasted period. Numerous scientific studies of the cannabinoid chemical have led to development of FDA-approved medications in pill form. The two main variations of cannabinoids derived from the cannabis plant are THC and CBD, which are used for medical purposes as treatments for various conditions such as increasing appetite, reduce nausea, decreasing pain, muscle control problems and more. The report also specifies that North America leads the market, holding about half of the market share in 2016. Medical Cannabis Payment Solutions (OTC: REFG), mCig, Inc. (OTC: MCIG), Future Farm Technologies Inc. (OTC: FFRMF), Kaya holdings, Inc. (OTC: KAYS), Mountain High Acquisitions Corp. (OTC: MYHI)

A report by CNBC quotes MedMen CEO and co-founder Adam Bierman, who explains the current state of the industry, "There is so much excitement now around legalization nationally coming in Canada. There is so much excitement about the fact that California, Nevada, Maine and Massachusetts all legalized recreational marijuana... The Canadian public markets offer access to a lot of capital, with a lot of certainty and a lot of speed, and there is this appetite among global investors to invest in a U.S. play. Specifically, global investors want to invest in a U.S. play that has California exposure. Now is the time where it makes the most sense."

Medical Cannabis Payment Solutions (OTC: REFG) just yesterday after the market close the company announced breaking news that, "it has acquired 40 acres of agricultural land to cultivate hemp as part of Utah's recently passed law, H.B. 302. The company will seek a license to grow hemp as part of the state's Department of Agriculture and Food licensing program.

In 2014, Utah passed H.B. 105, which allowed legal possession and use of CBD oil by registered patients with a doctor's recommendation and intractable epilepsy. The legislation, however, did not provide a mechanism for patients to acquire the oil. This year, Utah's legislature passed S.B. 130, the Cannabidiol Product Act, which authorized the cultivation, production, and possession of hemp and the sale and use of cannabidiol products.

"We have already purchased 40 acres in anticipation of acquiring a license to grow hemp as part of Utah's state-sanctioned system," said Jeremy Roberts, CEO of Medical Cannabis Payment Solutions. "With the acquisition of SpeedyGrow, we have now also entered the cultivation and extraction space. This will be the company's second license and facility."